Monsenso signs two contracts with the Psychiatric Research Unit, Region West Zealand.

Monsenso signs two contracts with the Psychiatric Research Unit, Region West Zealand.

Monsenso signs two contracts with Research Unit for Psychotherapy and Psychopathology, Psychiatry West, Slagelse, Region Zealand Mental Health Services, who will use Monsenso’s digital health solution to remotely monitor patients with depression and schizotypal mental illness, respectively.

The first project, Development of an Intervention for Persistent Not on Track: DIP NOT, led by Jasmin Rejaye Gryesten, aims to identify non-responders to depression treatment, with the ultimate goal of increasing the number of remitted patients after CBT in the Danish MHS by developing a set of new person-centered add-on interventions to group CBT, to be used in case of observed lack of progress or deterioration.

The second project Phenomenologically informed PsychoTherapy for patients with Schizotypal Personality Disorder (PPT -SPD), is led by Kåre Donskov Nielsen and aims to develop and test new forms of phenomenological therapy that can help people with schizotypal mental illness.

About Monsenso digital health solution:
The Monsenso solution is a clinically validated, CE Class I Marked mHealth solution classified as a Medical Device, consisting of a smartphone app for patients and a clinical web portal for healthcare providers that are widely used in the prevention and treatment of common behavioural disorders such as depression and anxiety. It can also be configured to prevent and treat severe mental illnesses such as depression, bipolar disorder, borderline personality disorder, PTSD, and schizophrenia. It is currently being used by over 1,000 patients across the globe and is highly valued by patients and healthcare providers.

For additional information contact:

Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Monsenso signs a new contract with Empano

Monsenso signs a new contract with Empano

Monsenso expands collaboration with Empano, a private provider of psychology and psychiatry services, signing a new contract to help citizens with stress return to work in the municipality of Slagelse.

Monsenso and Empano partnered up last year to help unemployed people get back to work faster. Together, Monsenso and Empano offer a solution for Danish municipalities to help unemployed people suffering from stress and depression return to work.
Following the successful implementation in the municipality of Guldborgssund, the services are now offered to more municipalities, starting in the municipality of Slagelse, Denmark.

Empano offers individual courses and group sessions to the employment sector in the municipalities and uses Monsenso’s digital health solution to collect self-reported data from service users to validate and demonstrate the program’s effectiveness.

The courses have a duration of 6-8 weeks each, after which new citizens are enrolled.

It is a preventative course that teaches strategies to reduce stress and promote mental health. Citizens are introduced to techniques that enable them to better cope with symptoms and challenges in everyday life and the job market, based on cognitive therapy, metacognitive therapy, and mindfulness.

“We are excited to expand our collaboration with Empano to help more people get back to work faster,” says CEO Thomas Lethenborg. “Mental health and unemployment are closely linked. While unemployment can cause stress which may have other negative consequences on people’s mental health, including depression, anxiety and lower self-esteem, a good mental health has shown to have a positive impact on employability, finding a job and staying in that job.”

Monsenso joins TSA, the industry body for Technology Enabled Care (TEC)

Monsenso joins TSA, the industry body for Technology Enabled Care (TEC)

Monsenso A/S, a leading provider of digital health solutions for mental health, joins TSA, the trade association for Technology Enabled Care (TEC), representing the largest sector-specific network in Europe and bringing together a growing number of organisations from local government, healthcare and the private sector.

TSA promotes and supports the technology-enabled care sector to health and social care commissioners, service users, their families and carers, including organising the annual International Technology Enabled Care Conference and promoting quality across the sector through its internationally recognised Integrated Code of Practice.

“We are delighted to become a member of TSA” Thomas Lethenborg, CEO of Monsenso, commented. “Working across NHS and social care, TSA will be a strong partner in our expansion in Europe and the UK.”

www.tsa-voice.org.uk / @TSAvoice

Monsenso signs a contract with the Elite Sports Academy Aarhus (ESAA)

Monsenso signs a contract with the Elite Sports Academy Aarhus (ESAA)

Monsenso signs a contract with the Elite Sports Academy Aarhus (ESAA). The Monsenso digital health solution will be used to promote mental wellbeing among ESAA’s students.

Strong mental health is a prerequisite for top athletes to perform at their best. Yet, top athletes are more vulnerable to psychological distress due to the top performance culture. In response, many clubs have over the recent years taken initiatives to promote mental health among their elite athletes and today sports psychology is as much about mental health, as it is about athletic performance.

ESAA, an Elite Sports Academy located in Aarhus (Denmark), is no exception. With mental health as part of the academy’s core values (Mind, Body, Culture, Team), ESAA seeks to provide their young athletes with self-insight and tools to learn how to master the mental aspects of being an elite athlete.

From August 2021, 75 young elite athletes will be offered the Monsenso mhealth app as part of ESAA’s talent program to track their mental wellbeing daily, while giving them access to “Tools” and “Challenges” to boost their mental health and wellbeing. ‘Tools’ provides the young athletes with coping strategies and ‘Challenges’ helps to learn new skills, like how to gain insight into their emotions, how to develop a positive mindset or improve their confidence.

At the same time, the daily tracking offers ESAA the opportunity to identify and act proactively upon signs and symptoms of mental distress, and hereby to provide preventive support to their young athletes.

 “We are pleased to collaborate with ESAA in this project,” says Thomas Lethenborg, CEO of Monsenso. “The importance of mental health in elite sport, in particular among young athletes, can not be underestimated and we are happy that the Monsenso solution can contribute to that. 

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

 

 

 

Monsenso signs new  contract with Psychiatric Centre of Copenhagen

Monsenso signs new contract with Psychiatric Centre of Copenhagen

Monsenso signs a new contract with the Psychiatric Centre of Copenhagen. The Monsenso digital health solution will be used to collect real-world data in the precision medicine research project “PRECISE”. 

The research project is led by Professor Michael E. Benros, head of research, Biological and Precision Psychiatry at the Copenhagen Research Centre for Mental Health at Copenhagen University Hospital and covers 100 patients with affective disorders.

Precision psychiatry initiative (PRECISE)

The purpose of the “PRECISE” study is to identify biological causes of psychiatric illnesses to identify objective markers for severe psychiatric illnesses by integrating big data from national registries and biobanks into detailed clinical data to improve clinical decision-making and treatment response. Currently, treatment options for mental illness are determined by a “one-size-fits-all” approach, resulting in an unacceptably large proportion of non-responding patients. Collecting and leveraging real-world data may enable more accurate diagnostics, prevention, and new treatment strategies. 

Real world-data collection on self-reported and behavioural data

The Monsenso digital health solution will be used to collect data on patient-reported outcomes through clinical questionnaires and daily self-assessments, as well as behavioural data from wearables. In addition, the patients will be offered in-app study information and can receive reminders about medication and consultations with their clinician.

 “We are pleased to expand our collaboration with the Psychiatric Centre of Copenhagen and proud to be contributing to the PRECISE project,” says Thomas Lethenborg, CEO of Monsenso. “Mental illness is the biggest disease burden in society in the 2020s. To reduce the burden, it is critical to leverage data to diagnose and monitor mental disorders correctly and to give the right treatment to the right patients. We are happy that the Monsenso solution can contribute to that.

For additional information contact:

Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Monsenso announces new chairman of the Board

Monsenso announces new chairman of the Board

Copenhagen, (April 14, 2021): Monsenso, a leading provider of digital mental health solutions, today announced the appointment of Maria Hjorth as Chairman of the Board, as replacement of Jukka Pekka Pertola, who had decided to resign to reduce his number of board seats. 

The company’s Annual General Meeting was held today, in which Maria Hjorth was elected to join the board. Immediately after the Annual General Meeting, the Board of Directors held its constituent meeting and elected Maria Hjorth as Chairman and re-elected Jakob Eyvind Bardram as Deputy Chairman.

The appointment of Maria Hjorth as chairman follows changes in January where Peter Høngaard Andensen and Jacob Hahn Michelsen were elected to the Board with the aim to further strengthen the competences and the diversity of the board.

 “Maria brings extensive experience and accomplishments from the financial sector, lately from a position as CEO at VP Securities A/S, in addition to her board experience from Trifork, May Invest Holding A/S and Asetek” says CEO Thomas Lethenborg. “Her experiences from top management, financial businesses, investor relations and M&A is a great supplement to the rest of the board”. 

The Board and the management of Monsenso would like to thank Jukka Pertola for his great efforts in supporting the management, the company in general and particularly the listing on Nasdaq First North Growth Market in 2020.

“It has been a great pleasure to have served as Chairman of the Monsenso Board of Directors,” said Jukka Pertola. “I am very proud of our accomplishments over the past years, and I am confident that with Maria’s leadership, and the changes made in January, Monsenso will continue to grow and expand it’s positive impact in driving better mental health for more people at lower cost.”

The Board of Directors now consists of Maria Hjorth (Chairman), Jakob E. Bardram (Deputy Chairman), Jeppe Ø. Øvlesen, Peter Høngaard Andersen and Jacob Hahn Michelsen. 

To read the Danish version, click here.

For additional information contact:

Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso